Skip to main content
Premium Trial:

Request an Annual Quote

CPTAC Releases Proteomic Data from TCGA Colorectal Cancer Samples

Premium

The National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium has publicly released its first proteomic data set.

Generated by Vanderbilt University's CPTAC Proteome Characterization Center led by researcher Daniel Liebler, the data consists of LC-MS/MS-based global proteomic profiles of 95 colorectal cancer samples that were also genomically characterized by The Cancer Genome Atlas effort.

Researchers interested in viewing the data can access it at the CPTAC Data Portal.

According to CPTAC, the consortium plans additional releases in the coming months, including a public assay portal for multiple-reaction monitoring mass spec assays; additional proteomic data sets including TCGA breast and ovarian cancer sets; and software to aid in the analysis of proteomic and genomic findings.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.